DODATNA NAVIGACIJA Projekt HRZZ: BrainToxProjekt HRZZ: WNT4EMTKardiovaskularni rizici u školske djece i mladihGenotip-fenotip korelacija u Alportovom sindromu i nefropatiji tankih glomerularnih bazalnih membranaProjekt HRZZ: COPERABiomarkers in schizophreniaProjekt HRZZ: MEFRAProjekt HRZZ: GALADRazvoj ciljane terapije infarkta u novom modelu dijabetesaProjekt HRZZ: BMP1-IsoForProjekt HRZZ: Reprogramiranje citoprotektivnih puteva u mezoteliomuUKF projekti Clinical and biological factors determining severity and activity of chronic graft- versus-host disease after allogeneic hematopoietic stem cell transplantationTrafficking of botulinum toxins in enteric nervous systemCytopathological characterization of the brain in a rat model of sporadic alzheimer’s diseaseProjekt HRZZ: Novi biomarkeri kronične bolesti presatka protiv primateljaProjekt HRZZ: epiSemProjekt HRZZ: BMP6Fe3Projekt HRZZ: epiProProjekt HRZZ: NOFIBROProjekt HRZZ: SMePROFProjekt HRZZ: VAL-DE-ENDProjekt HRZZ: ChildARTHRITISevolveEXPPANDProjekt HRZZ: BRADISCHEMIAProjekt HRZZ: NORAProjektHRZZ: BOBCatProjekt HRZZ: PRE-HYPOProjekt HRZZ – PURPURAPREDICTORSProjekt HRZZ: SepsisFATProjekt HRZZ: MEFCLOProjekt HRZZ: BrainECMProjekt HRZZ: SweetMitochondriaProjekt HRZZ: HepViroTRANSPLANT Početna stranica » Znanost » Istraživanje » Web stranice projekata » Projekt HRZZ: HepViroTRANSPLANTProjekt HRZZ: HepViroTRANSPLANTEmerging and Neglected Hepatotropic Viruses after Solid Organ and Hematopoietic Stem Cell TransplantationHepViroTRANSPLANT HRZZ Research Project (IP-2020-02-7407)Project leader (PI): Anna Mrzljak, MD, PhD, FEBGH; associate professorHost institution: University of Zagreb School of Medicine, Zagreb, Croatia Otvori sve Abstract Human viral hepatitis results from a wide range of pathogens beyond the classic primary hepatotropic viruses such as hepatitis A-E. Neglected secondary hepatotropic viruses (HVs) such as human herpes viruses 6/7 (HHV-6, HHV-7), parvovirus B19 (B19V), bocavirus (HBoV) may cause hepatic injury ranging from mild to fulminant hepatitis. In the impaired immunological setting, such as in patients after solid-organ transplantation (SOT) or after hematopoietic stem cell transplantation (HSCT), they may have particular effects and result in prolonged and disseminated disease. Several candidate viruses remain to be investigated as possible liver pathogens, including torque-teno virus (TTV), SEN virus (SENV), human pegivirus (HPgV), and non-primate hepaciviruses (NPHV).Given that Croatia has a high HSCT activity and one of the highest liver (32.20 pmp) and kidney (43.40 pmp) transplantation rates in the world, it would be of particular importance to investigate the impact of HVs in the context of transplantation outcomes.This prospective study will include SOT (liver/kidney) and HSCT candidates in order to identify the prevalence of nine emerging and neglected hepatotropic viruses (HEV, HHV-6, HHV-7, B19V, HBoV, TTV, SENV, HPgV, NPHV) before and within the first year after transplantation by detection of viral DNA/RNA and specific antibodies. The explanted liver samples after LT will also be tested. It is important to note that secondary HVs are not included in routine diagnostic testing; therefore, no or scarce data exist regarding the epidemiology in the region. The study will define the epidemiology, clinical characteristics, and impact of hepatotropic viruses in the pre-and post-transplant setting to improve transplant outcomes. Detection and genetic characterization of new HVs will enable a better understanding of the epidemiology of viral hepatitis in Croatia and South-East Europe, which will set a platform to improve public health measures and post-transplant management and outcomes. Project team members PROJECT TEAM MEMBERSAnna Mrzljak, Assoc. Prof. MD, Principal Investigatorhttps://scholar.google.com/citations?hl=en&user=z6kk_pUAAAAJ Ljubo Barbić, Prof. DVM, InvestigatorFaculty of Veterinary Medicine University of Zagreb, Croatiahttps://scholar.google.com/citations?hl=en&user=D5FtYWsAAAAJMaja Bogdanić, MD, PhD Student, Investigator Croatian Institute of Public Health, Zagreb, Croatiahttps://www.researchgate.net/profile/Maja-Bogdanic-2Maja Ilić, MD, InvestigatorCroatian Institute of Public Health, Zagreb, Croatiahttps://www.researchgate.net/profile/Maja-Ilic-4Ana Bainrauch (Jelić), MD, PhD Student, InvestigatorMerkur University Hospital, Zagreb, Croatiahttps://www.researchgate.net/profile/Ana-Jelic Lorena Jemeršić, Assoc. Prof. DVM, InvestigatorCroatian Veterinary Institute, Zagreb, Croatiahttps://scholar.google.com/citations?hl=en&user=np2ju6cAAAAJŽeljka Jureković, MD, InvestigatorMerkur University Hospitalhttps://www.linkedin.com/in/zeljka-jurekovic-27629217/?originalSubdomain=hrManuela Miletić, PhD, InvestigatorCroatian Institute for Transfusion Medicine, Zagreb, Croatiahttps://www.researchgate.net/profile/Manuela-MileticDanko Mikulić, MD, PhD, InvestigatorMerkur University Hospital, Zagreb, Croatiahttps://www.researchgate.net/profile/Danko-MikulicKarla Mišura, MD, PhD Student, InvestigatorMerkur University Hospital, Zagreb, Croatiahttps://www.linkedin.com/in/karla-mi%C5%A1ura-a9881661/?originalSubdomain=hrSlobodanka Ostojić Kolonić, Prof. MD, Investigator Medical School University of Zagrebhttps://scholar.google.com/citations?hl=en&user=x4K3UbEAAAAJ Nenad Pandak, MD, PhD, Investigator The Royal Hospital Muscat, Omanhttps://scholar.google.com/citations?hl=en&user=H417ccUAAAAJJadranka Pavičić Šarić, Assist. Prof. MD, InvestigatorMerkur University Hospital, Zagreb, Croatiahttps://scholar.google.com/citations?hl=en&user=zgJLC3sAAAAJVladimir Savić Assist. Prof. DVM, Investigator Croatian Veterinary Institutehttps://scholar.google.com/citations?hl=en&user=z4RzuRcAAAAJVladimir Stevanović, Assist. Prof. DVM, InvestigatorFaculty of Veterinary Medicine University of Zagrebhttps://scholar.google.com/citations?hl=en&user=AdTWhn8AAAAJTatjana Vilibić Čavlek, Assoc. Prof. MD, InvestigatorCroatian Institute of Public Health, Zagreb, Croatiahttps://scholar.google.com/citations?hl=en&user=oEd2oVMAAAAJAdriana Vince, Prof. MD, Investigator School of Medicine, University of Zagrebhttps://scholar.google.com/citations?hl=en&user=F5oKXo8AAAAJ Project funding and duration Project duration: 48 months (01.01.2021. – 01.12.2024.)Project funding: 1,500.000 HRK Project summary & objectives Project results Otvori svePrijava projekataFinanciranje projekataDomaći projektiMeđunarodni projektiWeb stranice projekata Projekt HRZZ: BrainToxProjekt HRZZ: WNT4EMTKardiovaskularni rizici u školske djece i mladihGenotip-fenotip korelacija u Alportovom sindromu i nefropatiji tankih glomerularnih bazalnih membranaProjekt HRZZ: COPERABiomarkers in schizophreniaProjekt HRZZ: MEFRAProjekt HRZZ: GALADRazvoj ciljane terapije infarkta u novom modelu dijabetesaProjekt HRZZ: BMP1-IsoForProjekt HRZZ: Reprogramiranje citoprotektivnih puteva u mezoteliomuUKF projektiClinical and biological factors determining severity and activity of chronic graft- versus-host disease after allogeneic hematopoietic stem cell transplantationTrafficking of botulinum toxins in enteric nervous systemCytopathological characterization of the brain in a rat model of sporadic alzheimer’s diseaseProjekt HRZZ: Novi biomarkeri kronične bolesti presatka protiv primateljaProjekt HRZZ: epiSemProjekt HRZZ: BMP6Fe3Projekt HRZZ: epiProProjekt HRZZ: NOFIBROProjekt HRZZ: SMePROFProjekt HRZZ: VAL-DE-ENDProjekt HRZZ: ChildARTHRITISevolveEXPPANDProjekt HRZZ: BRADISCHEMIAProjekt HRZZ: NORAProjektHRZZ: BOBCatProjekt HRZZ: PRE-HYPOProjekt HRZZ – PURPURAPREDICTORSProjekt HRZZ: SepsisFATProjekt HRZZ: MEFCLOProjekt HRZZ: BrainECMProjekt HRZZ: SweetMitochondriaProjekt HRZZ: HepViroTRANSPLANTZnanstvenoistraživački radLaboratoriji GlowLab – Laboratorij za regenerativnu neuroznanostIntelektualno vlasništvoObavijesti
Clinical and biological factors determining severity and activity of chronic graft- versus-host disease after allogeneic hematopoietic stem cell transplantationTrafficking of botulinum toxins in enteric nervous systemCytopathological characterization of the brain in a rat model of sporadic alzheimer’s disease
Human viral hepatitis results from a wide range of pathogens beyond the classic primary hepatotropic viruses such as hepatitis A-E. Neglected secondary hepatotropic viruses (HVs) such as human herpes viruses 6/7 (HHV-6, HHV-7), parvovirus B19 (B19V), bocavirus (HBoV) may cause hepatic injury ranging from mild to fulminant hepatitis. In the impaired immunological setting, such as in patients after solid-organ transplantation (SOT) or after hematopoietic stem cell transplantation (HSCT), they may have particular effects and result in prolonged and disseminated disease. Several candidate viruses remain to be investigated as possible liver pathogens, including torque-teno virus (TTV), SEN virus (SENV), human pegivirus (HPgV), and non-primate hepaciviruses (NPHV).Given that Croatia has a high HSCT activity and one of the highest liver (32.20 pmp) and kidney (43.40 pmp) transplantation rates in the world, it would be of particular importance to investigate the impact of HVs in the context of transplantation outcomes.This prospective study will include SOT (liver/kidney) and HSCT candidates in order to identify the prevalence of nine emerging and neglected hepatotropic viruses (HEV, HHV-6, HHV-7, B19V, HBoV, TTV, SENV, HPgV, NPHV) before and within the first year after transplantation by detection of viral DNA/RNA and specific antibodies. The explanted liver samples after LT will also be tested. It is important to note that secondary HVs are not included in routine diagnostic testing; therefore, no or scarce data exist regarding the epidemiology in the region. The study will define the epidemiology, clinical characteristics, and impact of hepatotropic viruses in the pre-and post-transplant setting to improve transplant outcomes. Detection and genetic characterization of new HVs will enable a better understanding of the epidemiology of viral hepatitis in Croatia and South-East Europe, which will set a platform to improve public health measures and post-transplant management and outcomes.
PROJECT TEAM MEMBERSAnna Mrzljak, Assoc. Prof. MD, Principal Investigatorhttps://scholar.google.com/citations?hl=en&user=z6kk_pUAAAAJ Ljubo Barbić, Prof. DVM, InvestigatorFaculty of Veterinary Medicine University of Zagreb, Croatiahttps://scholar.google.com/citations?hl=en&user=D5FtYWsAAAAJMaja Bogdanić, MD, PhD Student, Investigator Croatian Institute of Public Health, Zagreb, Croatiahttps://www.researchgate.net/profile/Maja-Bogdanic-2Maja Ilić, MD, InvestigatorCroatian Institute of Public Health, Zagreb, Croatiahttps://www.researchgate.net/profile/Maja-Ilic-4Ana Bainrauch (Jelić), MD, PhD Student, InvestigatorMerkur University Hospital, Zagreb, Croatiahttps://www.researchgate.net/profile/Ana-Jelic Lorena Jemeršić, Assoc. Prof. DVM, InvestigatorCroatian Veterinary Institute, Zagreb, Croatiahttps://scholar.google.com/citations?hl=en&user=np2ju6cAAAAJŽeljka Jureković, MD, InvestigatorMerkur University Hospitalhttps://www.linkedin.com/in/zeljka-jurekovic-27629217/?originalSubdomain=hrManuela Miletić, PhD, InvestigatorCroatian Institute for Transfusion Medicine, Zagreb, Croatiahttps://www.researchgate.net/profile/Manuela-MileticDanko Mikulić, MD, PhD, InvestigatorMerkur University Hospital, Zagreb, Croatiahttps://www.researchgate.net/profile/Danko-MikulicKarla Mišura, MD, PhD Student, InvestigatorMerkur University Hospital, Zagreb, Croatiahttps://www.linkedin.com/in/karla-mi%C5%A1ura-a9881661/?originalSubdomain=hrSlobodanka Ostojić Kolonić, Prof. MD, Investigator Medical School University of Zagrebhttps://scholar.google.com/citations?hl=en&user=x4K3UbEAAAAJ Nenad Pandak, MD, PhD, Investigator The Royal Hospital Muscat, Omanhttps://scholar.google.com/citations?hl=en&user=H417ccUAAAAJJadranka Pavičić Šarić, Assist. Prof. MD, InvestigatorMerkur University Hospital, Zagreb, Croatiahttps://scholar.google.com/citations?hl=en&user=zgJLC3sAAAAJVladimir Savić Assist. Prof. DVM, Investigator Croatian Veterinary Institutehttps://scholar.google.com/citations?hl=en&user=z4RzuRcAAAAJVladimir Stevanović, Assist. Prof. DVM, InvestigatorFaculty of Veterinary Medicine University of Zagrebhttps://scholar.google.com/citations?hl=en&user=AdTWhn8AAAAJTatjana Vilibić Čavlek, Assoc. Prof. MD, InvestigatorCroatian Institute of Public Health, Zagreb, Croatiahttps://scholar.google.com/citations?hl=en&user=oEd2oVMAAAAJAdriana Vince, Prof. MD, Investigator School of Medicine, University of Zagrebhttps://scholar.google.com/citations?hl=en&user=F5oKXo8AAAAJ
Projekt HRZZ: BrainToxProjekt HRZZ: WNT4EMTKardiovaskularni rizici u školske djece i mladihGenotip-fenotip korelacija u Alportovom sindromu i nefropatiji tankih glomerularnih bazalnih membranaProjekt HRZZ: COPERABiomarkers in schizophreniaProjekt HRZZ: MEFRAProjekt HRZZ: GALADRazvoj ciljane terapije infarkta u novom modelu dijabetesaProjekt HRZZ: BMP1-IsoForProjekt HRZZ: Reprogramiranje citoprotektivnih puteva u mezoteliomuUKF projektiClinical and biological factors determining severity and activity of chronic graft- versus-host disease after allogeneic hematopoietic stem cell transplantationTrafficking of botulinum toxins in enteric nervous systemCytopathological characterization of the brain in a rat model of sporadic alzheimer’s diseaseProjekt HRZZ: Novi biomarkeri kronične bolesti presatka protiv primateljaProjekt HRZZ: epiSemProjekt HRZZ: BMP6Fe3Projekt HRZZ: epiProProjekt HRZZ: NOFIBROProjekt HRZZ: SMePROFProjekt HRZZ: VAL-DE-ENDProjekt HRZZ: ChildARTHRITISevolveEXPPANDProjekt HRZZ: BRADISCHEMIAProjekt HRZZ: NORAProjektHRZZ: BOBCatProjekt HRZZ: PRE-HYPOProjekt HRZZ – PURPURAPREDICTORSProjekt HRZZ: SepsisFATProjekt HRZZ: MEFCLOProjekt HRZZ: BrainECMProjekt HRZZ: SweetMitochondriaProjekt HRZZ: HepViroTRANSPLANT